| |
|
|
|
Tenax Therapeutics Inc.  
|
|
1.45 -0.02 (-0.01%) |
05-22 15:59 |
|
Open: |
1.48 |
Pre close: |
1.47 |
Target:
|
1.93
|
|
High: |
1.48 |
Low: |
1.41 |
Resistance:
|
1.65
1.86
|
|
Volume: |
116,079 |
Market Cap: |
9M |
Support:
|
1.31
1.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.39
 |
MACD |
MACD(12,26):
|
-0.08 |
|
MA(20): |
1.54  |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
1.50 |
Stochastic Oscillator |
%K(14,3):
|
27.39 |
|
MA(250): |
3.60 |
%D(3): |
16.77 |
|
Average Volume(K) |
3-Month: |
110704
|
52-Week |
High:
|
7.20 |
|
10-Days: |
12621 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
42.59 |
Change(%): |
-75.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-139.5 |
Shares Out. (M) |
6.19 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-124.0 |
Shares Float (M) |
4.54 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.30 |
|
Forward EPS |
-2.633 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.710 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.07 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.22 |
P/CF |
-1.48 |
|
|
|
|
|
|
